Understanding and managing the suppression of spermatogenesis caused by testosterone replacement therapy (TRT) and anabolic–androgenic steroids (AAS)

Use of testosterone replacement therapy (TRT) and anabolic–androgenic steroids (AAS) has increased over the last 20 years, coinciding with an increase in men presenting with infertility and hypogonadism. Both agents have a detrimental effect on spermatogenesis and pose a clinical challenge in the se...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Ankit, Yassin, Musaab, Cayetano, Axel, Tharakan, Tharu, Jayasena, Channa N., Minhas, Suks
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243576/
https://www.ncbi.nlm.nih.gov/pubmed/35783920
http://dx.doi.org/10.1177/17562872221105017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243576/
https://www.ncbi.nlm.nih.gov/pubmed/35783920
http://dx.doi.org/10.1177/17562872221105017

Ejemplares similares